Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig. 5 F'
Azbazdar Y and De Robertis EM (2024) |
Xla Wt + szl MO
NF28 (in situ hybridization) |
|
|||||
![]() |
Fig S6 E
Zhang Z et al. (2016) |
Xla Wt + sdc4 MO + szl MO
NF19 (in situ hybridization) |
|
|||||
![]() |
Fig S6 J
Zhang Z et al. (2016) |
Xla Wt + sdc4 MO + szl MO
NF19 (in situ hybridization) |
|
|||||
![]() |
Fig S6 O
Zhang Z et al. (2016) |
Xla Wt + sdc4 MO + szl MO
NF19 (in situ hybridization) |
|
|||||
![]() |
fig.S2.c
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF10.5 (in situ hybridization) |
|
|||||
![]() |
fig.8.a
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF10.5 (in situ hybridization) |
|
|||||
![]() |
fig.8.a
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF18-20 (immunohistochemistry) |
|
|||||
![]() |
fig.8.a
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF18-20 (in situ hybridization) |
|
|||||
![]() |
fig.7.a
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF18-20 (morphology) |
|
|||||
![]() |
fig.3.c
Kenny AP et al. (2012) |
Xla Wt + szl MO
NF20 (in situ hybridization) |
|